June 14, 2011
Novartis Pharma AG resolved a patent infringement suit Monday in New Jersey over Sun Pharmaceutical Industries Ltd.'s proposed generic version of Novartis' attention deficit disorder drug Focalin after receiving government approval of a settlement agreement.